Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,519.12
(
0.61%
)
US TECH 100
29,229.20
(
1.84%
)
Dow Jones
50,461.68
(
-0.23%
)
Brent Oil
96.02
(
-1.00%
)
Bitcoin
75,784.24
(
-0.08%
)
News Focus
News Focus
Post# of 257644
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 123024
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: ghmm post# 88464

Monday, 01/04/2010 5:19:38 PM

Monday, January 04, 2010 5:19:38 PM

Post# of 257644
The Merz buyout of BFRM makes a lot of sense, but I was so focused on JNJ as a prospective BFRM suitor that I overlooked the move by Merz.

Merz will now have both the best neurotoxin and the best dermal filler on the market, which means they’ll benefit from cross-selling opportunities coming and going. Too bad we can't buy their stock.


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today